gastroparesis and glp 1 GLP-1 receptor agonists delayed gastric emptying: implications for invasive cardiac interventions and surgery gastroparesis glp 1 agonist Gastrointestinal
Description
Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population
Secondary outcomes included the incidence of aborted EGDs due to GRC, the effect of concurrent CLN on GRC, and a comparison of GRC risk among different GLP-1 RA agents
7g of fiber and 14g of protein per serving*
Discover the science behind this weight loss medication and what to expect on your journey.
Childhood obesity has assumed epidemic proportions
